Olson Kenneth Fletcher
Known title: Chief Operating OfficerCIK: 0001793360
Associated companies
Transaction History
| HBIO | ▼ Sell | Tax Withholding | 2,812 | $20K | 12/29/2021 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 3,347 | $24K | 12/29/2021 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 1,539 | $11K | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Harvard Bioscience Forms Scientific Advisory Board
Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.
Harvard Bioscience Forms Scientific Advisory Board. Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.